Somatostatin-28 1-14 is primarily used in research and medical applications due to its role in regulating various physiological processes. It is a fragment of somatostatin-28, which is known for its inhibitory effects on hormone secretion. In research, it is utilized to study its impact on the endocrine system, particularly in controlling the release of growth hormone, insulin, and glucagon. This peptide is also explored for its potential therapeutic applications in conditions like acromegaly, where excessive growth hormone production occurs, and in managing certain types of tumors that are hormone-sensitive. Additionally, it is investigated for its role in modulating neurotransmission and its effects on the central nervous system, providing insights into neurological disorders.